Advancing proprietary AI discovery of high-bioavailability Oral GLP-1 drug candidates. HOUSTON, Feb. 3, 2026 /PRNewswire/ -- Deep EigenMatics, Inc., a pioneer in high-velocity Artificial Intelligence for drug design, announced today that it has secured the #1 global ranking for new U.S....
Hence then, the article about deep eigenmatics ranks 1 globally in ai drug discovery outpacing all of big pharma in 2025 patent output was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Deep EigenMatics Ranks 1 Globally in AI Drug Discovery, Outpacing All of Big Pharma in 2025 Patent Output )
Also on site :
- Money Talks: This Season on ‘Industry’
- OSRS Leagues 6: Demonic Pacts release date, rewards and what to expect
- ‘I graduated with £84k student loan debt – I’ve applied for 60 jobs but can only get a part-time shop role’